PRF Technologies Ltd. Ordinary Shares

PRFX

PainReform Ltd. is a clinical-stage biopharmaceutical company focused on developing and commercializing treatments for chronic pain conditions. The company utilizes novel proprietary drug delivery technologies to enhance the efficacy and safety of pain management therapies. PainReform's pipeline emphasizes non-opioid solutions aimed at providing long-lasting relief for patients with unmet needs in pain treatment.

$0.84 -0.08 (-9.03%)
🚫 PRF Technologies Ltd. Ordinary Shares does not pay dividends

Company News

PainReform’s DeepSolar Launches Smart TDD, a Next-Generation Solar Due Diligence Service Targeting the $60B+ Global Solar Asset M&A Market
GlobeNewswire Inc. • Painreform Ltd. • January 5, 2026

PainReform's DeepSolar business unit launched Smart TDD, an advanced solar Technical Due Diligence service designed to provide faster and more comprehensive assessments of solar asset performance. The service targets the $60+ billion annual solar asset M&A market by offering complete data coverage, AI-driven diagnostics, and rapid turnaround to s...

BladeRanger to Showcase Advanced Green Energy Technologies at Abu Dhabi Sustainability Week
Benzinga • Prnewswire • December 30, 2025

BladeRanger (TASE: BLRN), a drone-based inspection and AI analytics provider for green energy infrastructure, will showcase its Solar Drone and DeepSolar platforms at Abu Dhabi Sustainability Week. The company is expanding its regional presence in the UAE, where $600 billion is being invested in hyperscale data centers and renewable energy system...

PainReform Ltd. Completes Strategic Investment in LayerBio to Enter $9B Global Cataract Surgery Market with Breakthrough Non-Opiate, Non-Steroidal Postoperative NSAID Drug Delivery System
Benzinga • Globe Newswire • August 13, 2025

PainReform Ltd. has acquired a majority equity stake in LayerBio, a biotechnology company developing a breakthrough non-opiate, non-steroidal drug delivery system for postoperative pain management in cataract surgery, targeting the $9B global market.

Blade Ranger: Consideration from PainReform Transaction Continues to Mature Following Growth in Software Sales
Benzinga • Prnewswire • May 27, 2025

Blade Ranger Ltd. announced the achievement of a first milestone in the transaction involving the sale of its DeepSolar operations to PainReform. As a result of increased software sales by PainReform, Blade Ranger has received additional warrants worth approximately $2 million, significantly improving its financial flexibility.

PainReform Expands into Home Energy Management Sector, Leveraging DeepSolar's AI-Driven Platform to Address the Growing Solar Optimization Market
Benzinga • Globe Newswire • April 10, 2025

PainReform Ltd. has acquired DeepSolar, a provider of AI-driven software solutions to optimize solar energy usage. This strategic expansion marks PainReform's entry into the rapidly growing Smart Energy Management sector, leveraging DeepSolar's technology to address the growing solar optimization market.

Related Companies